[1]
S. Sukhodolya, T. Falalyeyeva, O. Kuryk, V. Petrushenko, and T. Beregova, “Evidence of use: A selective COX-2 inhibitor in the treatment of experimental chronic pancreatitis induced by Dibutyltin dichloride”, Curr. Issues Pharm. Med. Sci., vol. 28, no. 2, pp. 131–135, Jul. 2015, doi: 10.1515/cipms-2015-0059.